Near term catalyst discussion

I thought I'd create a new thread to discuss the potential near term catalysts for Mesoblast (and for fun throw in some speculation on the possibility that these will be positive)

Here's what I'm thinking off the top of my head

1. OTAT's signs off on the CMC and CQA process suitability (better than average due to advice from FDA on approach)

2. Confirmatory Covid trial gets green light and funding from Novartis (well they're still here so better than average)

3. Dr Perin publishes his article in NEJM with "amazing results" for CHF (near certainty as indicated by the Doc himself)

4. MSB gets clear indication of positive regulatory pathway for Rex-L for CLBP from FDA (50/50?)

5. Surgecenter comes forward to partner with MSB on a confirmatory trial for CLBP as per FDA guidance (speculative)

6. Crohn's disease study reports favorable outcomes for direct injection approach (better than average)

7. New Covid trial meets primary endpoint (given all the data they have had to analyse from the last trial - better than average)

8. Over 65's respond to new dosing in Covid trial (speculative)